StockData
OS Therapies Inc logo

OS Therapies Inc (OSTX) stock

OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.74+0.06 (+9.42%)

Close on Nov 17, 2026Market cap $34.35MP/E –Yield –

OS Therapies operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

OS Therapies's operating cash flow for the twelve months ending Jun 30, 2026 was -$18.53M. For fiscal 2025 it was -$14.24M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.24M–
FY2024Dec 31, 2024-$7.28M–
FY2023Dec 31, 2023-$3.01M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.53M–
Q1 FY2026Mar 31, 2026-$4.56M–
Q4 FY2025Dec 31, 2025-$3.73M–
Q3 FY2025Sep 30, 2025-$4.71M–
Q2 FY2025Jun 30, 2025-$2.36M–
Q1 FY2025Mar 31, 2025-$3.44M–
Q4 FY2024Dec 31, 2024-$2.37M–
Q3 FY2024Sep 30, 2024-$3.38M–
Q2 FY2024Jun 30, 2024-$881.19K–
Q1 FY2024Mar 31, 2024-$641.73K–
Q4 FY2023Dec 31, 2023-$871.16K–
Q3 FY2023Sep 30, 2023-$876.57K–
Q2 FY2023Jun 30, 2023-$831.05K–
Q1 FY2023Mar 31, 2023-$428.19K–

More OS Therapies figures

See a number that looks wrong?